News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Prime Therapeutics Proves Cox-2 Pre-authorization Is Effective In Reducing Pharmacy Costs For Blue Cross And Blue Shield Of Nebraska Without Compromising Medical Costs



10/19/2005 5:08:59 PM

Prime Therapeutics (Prime), a pharmacy benefits manager, and Blue Cross and Blue Shield of Nebraska implemented a Cox-2 pre-authorization program that effectively decreased pharmacy costs. The results of a 12-month study of the Cox-2 pre-authorization program show a decrease in pharmacy costs of $0.99 per member per month (PMPM) and a return on investment of 3.8.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES